Trinity Biotech plc (ADR) (NASDAQ:TRIB)
CAPS Rating:
The Company develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market.
The Company develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market.
Recs
I work in health care, and I believe point of care diagnostics is the wave of the future, as it has clear advantages for both the patient and the heatlth care industry, from convenience to time and cost efficiency.